Objective. To assess circulating follicular helper-like CD4 + T (cTfh-like) cells in systemic lupus erythematosus (SLE) and determine their relationship to disease activity.
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Systemic lupus erythematosus (SLE, lupus) is marked by immune complexmediated tissue injury in multiple organs. The clinical manifestations and the immunoregulatory factors that contribute to disease are diverse. Identification of common pathogenic pathways and the corresponding biomarkers that link abnormal cellular activity to disease activity are necessary to define therapeutic targets.
Central to antibody production is the collaboration between CD4 + T cells and B cells in germinal centers (GC) of secondary lymphoid organs (SLOs), the site of immunoglobulin (Ig) isotype switching and affinity maturation, with the subsequent genesis of memory B cells and long-lived plasma cells (PCs) (reviewed in (1, 2) ).
Pathogenic autoantibodies in murine and human lupus are also class-switched and somatically mutated with affinity maturation (3, 4) , and arise from autoreactive memory B cells upon restimulation (5-7), features consistent with GC selection. The role of aberrant GC responses in the autoantibody genesis finds support in the observation that spontaneous GCs form in murine lupus (8) , with evidence of exuberant GC activity in patients with active lupus nephritis (9). These data indicate that autoreactive B-cell maturation occurs in GCs in SLE.
Follicular B-helper T (Tfh) cells are necessary for T cell-dependent B-cell maturation in the GC (reviewed in (1, 2) ). Tfh cells express the transcription factor Bcell lymphoma 6 (Bcl6) that drives a gene program critical for their development and function (10) (11) (12) . Tfh cells are identified by a combination of markers, including CXCR5
(C-X-C chemokine receptor type 5) that enables their migration along a CXCL13 (C-X-C motif chemokine 13) gradient into B-cell follicles with subsequent GC formation (13, 14) ;
ICOS (inducible T-cell costimulator), necessary for development of nascent Tfh cells 4 upon their activation by dendritic cells (DCs) expressing ICOS ligand (ICOS-L) (15), and
for their subsequent expansion upon interactions with ICOS-L expressed on B cells (16, 17) ; and PD-1 (programmed cell death protein-1; also PCDC1), which provides inhibitory signals to T cells (18), but also regulates GC B-cell selection and survival necessary for formation of long-lived PCs (19) of the type observed in SLE (4, 7) . Tfh cells secrete interleukin (IL)-21, critical for GC development and maintenance (20, 21) , and for Ig class switching and PC development (22) . Aberrant expansion of Tfh cells is causally linked to abundant GCs, autoantibodies, and end-organ damage in murine lupus (23) (24) (25) . Phenotypically similar T cells (20, 24) drive autoreactive B-cell responses occurring outside of GCs in murine SLOs (26) and in the kidneys of SLE patients (27) . Thus, Tfh cells are central to disease in mice and humans.
Although human Tfh cells can be analyzed in spleens and tonsils, their assessment in SLE has been hampered by the inability to routinely sample SLOs. for Macintosh; GraphPad Software). Given the correlation between PD-1 expression on CXCR5 hi cells and disease activity, we asked if the former were linked to organ involvement (Table 1 ). In patients with proteinuria and hematuria, compared to those without, we found an increase in PD- Figure 3G and H, respectively); removal of outliers had no effect on statistical analyses.
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